These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 795438)
1. Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication. Zimmer BD; Bickel P; Dittrich A Arzneimittelforschung; 1976; 26(8):1614-6. PubMed ID: 795438 [TBL] [Abstract][Full Text] [Related]
2. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. Roberts JD; Gennings C; Shih M Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146 [TBL] [Abstract][Full Text] [Related]
4. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Curran HV; Brignell C; Fletcher S; Middleton P; Henry J Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529 [TBL] [Abstract][Full Text] [Related]
6. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271 [TBL] [Abstract][Full Text] [Related]
7. Effect of intrapulmonary tetrahydrocannabinol administration in humans. Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447 [TBL] [Abstract][Full Text] [Related]
8. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans. Carlini EA Toxicon; 2004 Sep; 44(4):461-7. PubMed ID: 15302527 [TBL] [Abstract][Full Text] [Related]
9. Delta-9-tetrahydrocannabinol (THC) as an antiemetic. Kluin-Nelemans JC; Meuwissen OJ; Nelemans FA; Maes RA N Engl J Med; 1980 Jun; 302(24):1364-5. PubMed ID: 6246424 [No Abstract] [Full Text] [Related]
10. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. Heyser CJ; Hampson RE; Deadwyler SA J Pharmacol Exp Ther; 1993 Jan; 264(1):294-307. PubMed ID: 8380864 [TBL] [Abstract][Full Text] [Related]
12. Delta-9-tetrahydrocannabinol (THC) as an antiemetic. Zeltzer L; Barbour J; LeBaron S; Kellerman J N Engl J Med; 1980 Jun; 302(24):1364. PubMed ID: 6246423 [No Abstract] [Full Text] [Related]
13. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol. Lemberger L; Martz R; Rodda B; Forney R; Rowe H J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. Gold LH; Balster RL; Barrett RL; Britt DT; Martin BR J Pharmacol Exp Ther; 1992 Aug; 262(2):479-86. PubMed ID: 1323651 [TBL] [Abstract][Full Text] [Related]
16. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol. McMillan DE; Leander JD; Dudley KH J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628 [TBL] [Abstract][Full Text] [Related]
17. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart. Hillard CJ; Pounds JJ; Boyer DR; Bloom AS J Pharmacol Exp Ther; 1990 Mar; 252(3):1075-82. PubMed ID: 2156989 [TBL] [Abstract][Full Text] [Related]
18. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. Cadoni C; Valentini V; Di Chiara G J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369 [TBL] [Abstract][Full Text] [Related]
19. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. Beardsley PM; Scimeca JA; Martin BR J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218 [TBL] [Abstract][Full Text] [Related]
20. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices. Reichman M; Nen W; Hokin LE Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]